For some, walking may merely be a form of exercise. For others, it may also be a means for getting from one place to another. Adjaye-Gbeywonyo and Briones (2024) used 2022 National Health Interview Survey data to determine the percentage of adults in the United States who walked for leisure and those who walked for transportation.
A positive response for walking for transportation was a “yes” response to the question, “The next questions are about walking for transportation. This is walking you might have done to travel to and from work, to do errands, or to go from place to place. I will ask you separately about walking for other reasons like relaxation, exercise, or walking the dog. In the past 7 days, did you walk for transportation?”
A positive response for walking for leisure, on the other hand, was a “yes” response to the question related to walking “for fun, relaxation, exercise, or to walk the dog.” These authors found that less than 20 percent (16.2 percent) of adults walked for transportation; while close to 60 percent (58.7 percent) walked for leisure.
Adjaye-Gbeywonyo and Briones (2024) also explored the relationship between selected sociodemographic factors and their purpose for walking in that time frame. This information may be important when you consider how your patients might be getting to your appointments and how they are spending their leisure time.
Reference
Adjaye-Gbewonyo D, Briones EM. (2024) Walking for leisure and transportation among adults: United States, 2022. NCHS Data Brief (504).
Recent Posts
How Do Animals Perceive Music?
Music can be defined as vocal, instrumental, or mechanical sounds, with rhythm, melody or harmony, and often, an expression of human emotion. Music can transcend…
‘Eye’ on Health: AI Detects Dizziness and Balance Disorders Remotely
Interesting research led by audiologist Ali Danesh, PhD, at Florida Atlantic University (FAU) helped develop a novel, proof-of-concept tool to help identify nystagmus using a…
Rizatriptan vs. Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial
Jeffrey Staab, MD, and colleagues studied the effectiveness of rizatriptan as a treatment option for vestibular migraine. Their research included 134 patients between the ages of…